Mexiletine: An adjuvant option for refractory pain in patients with sickle cell disease and comorbid autism spectrum disorder

Nour K. Kadouh, Stacy Lang, Mark Shamoun, Eric L. Scott, Sharon A. Singh, Michael A. Smith

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
JournalPediatric Blood and Cancer
DOIs
StateAccepted/In press - 2021
Externally publishedYes

Fingerprint

Dive into the research topics of 'Mexiletine: An adjuvant option for refractory pain in patients with sickle cell disease and comorbid autism spectrum disorder'. Together they form a unique fingerprint.

Cite this